OrbiMed Advisors
Venture capital firm · Founded 1998 · New York, NY · New York ↗
OrbiMed Advisors is a New York-based investment firm founded in 1998 that invests across public equity, private equity and venture capital exclusively in the healthcare and life sciences industries.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at OrbiMed Advisors, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$21B
Latest fund
OrbiMed Private Investments X$1.9B · 2026
Funds
10
Check size
LAST CHECKED NOV 2026
Stages
GrowthSeed
Sectors
healthcarelife sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 8
- Carl Gordon
General Partner
Board seats
No public record - Jonathan Silverstein
General Partner
Board seats
No public record - Samuel Isaly
Founder, Managing Partner
Board seats
No public record - Sven Borho
General Partner
Board seats
No public record - Geoffrey Hsu
General Partner
Board seats
No public record - Carter Neild
General Partner
Board seats
1 current
- Scot Stevens
General Partner
Board seats
No public record - David Bonita
General Partner
Board seats
3 current
Reputation 2
No reputation score — basis not established for this firm.
- About OrbiMed - firm site
orbimed.com
- OrbiMed - Wikipedia
en.wikipedia.org
Contact
Published sources only
Published contact
- Website
- orbimed.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with OrbiMed Advisors. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — AUM US$18B (March 2024) per Wikipedia infobox — meets the tier-1 AUM prong (>= $10B). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for OrbiMed Advisors — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Reputation
- [2]
FIRM SITE · OrbiMed Advisors — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
